Literature DB >> 11308027

Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.

S Hinderlich1, M Berger, O T Keppler, M Pawlita, W Reutter.   

Abstract

The first two steps in mammalian biosynthesis of N-acetylneuraminic acid, an important carbohydrate moiety in biological recognition systems, are performed by the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. A subclone of the human B lymphoma cell line BJA-B K20, lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase mRNA as well as epimerase activity, displayed hyposialylated, functionally impaired cell surface glycoconjugates. Here we show that this cell line surprisingly still retains N-acetylmannosamine kinase activity. A gel filtration analysis of BJA-B K88 control cells, which express UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, revealed two N-acetylmannosamine kinase activity peaks, one co-eluting with UDP-N-acetylglucosamine 2-epimerase activity and one co-eluting with N-acetylglucosamine kinase. For this enzyme previous studies already showed a ManNAc kinase activity in vitro. In contrast, the hyposialylated BJA-B K20 subclone displayed only the N-acetylmannosamine kinase peak, co-migrating with N-acetylglucosamine kinase. The CMP-N-acetylneuraminic acid content of both K88 and K20 cells and the sialylation of cell surface glycoconjugates of K20 cells could be significantly increased by supplementing the medium with N-acetylmannosamine. This N-acetylmannosamine-induced increase was drastically reduced by co-supplementation with N-acetylglucosamine only in K20 cells. We therefore propose the phosphorylation of N-acetylmannosamine as a hitherto unrecognized role of N-acetylglucosamine kinase in living cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308027     DOI: 10.1515/BC.2001.036

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  22 in total

1.  Sialylation is essential for early development in mice.

Authors:  Martina Schwarzkopf; Klaus-Peter Knobeloch; Elvira Rohde; Stephan Hinderlich; Nicola Wiechens; Lothar Lucka; Ivan Horak; Werner Reutter; Rüdiger Horstkorte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

Review 2.  Sialylation in protostomes: a perspective from Drosophila genetics and biochemistry.

Authors:  Kate Koles; Elena Repnikova; Galina Pavlova; Leonid I Korochkin; Vladislav M Panin
Journal:  Glycoconj J       Date:  2008-06-21       Impact factor: 2.916

3.  Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis.

Authors:  Kunio Kawanishi; Sudeshna Saha; Sandra Diaz; Michael Vaill; Aniruddha Sasmal; Shoib S Siddiqui; Biswa Choudhury; Kumar Sharma; Xi Chen; Ian C Schoenhofen; Chihiro Sato; Ken Kitajima; Hudson H Freeze; Anja Münster-Kühnel; Ajit Varki
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

4.  Molecular diagnosis of hereditary inclusion body myopathy by linkage analysis and identification of a novel splice site mutation in GNE.

Authors:  Steven E Boyden; Anna R Duncan; Elicia A Estrella; Hart G W Lidov; Lane J Mahoney; Jonathan S Katz; Louis M Kunkel; Peter B Kang
Journal:  BMC Med Genet       Date:  2011-06-28       Impact factor: 2.103

5.  Multivalent ligands for siglecs.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

6.  A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ichizo Nishino
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

Review 7.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

8.  A Chemical Biology Solution to Problems with Studying Biologically Important but Unstable 9-O-Acetyl Sialic Acids.

Authors:  Zahra Khedri; An Xiao; Hai Yu; Corinna Susanne Landig; Wanqing Li; Sandra Diaz; Brian R Wasik; Colin R Parrish; Lee-Ping Wang; Ajit Varki; Xi Chen
Journal:  ACS Chem Biol       Date:  2016-12-12       Impact factor: 5.100

9.  Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.

Authors:  Terren K Niethamer; Tal Yardeni; Petcharat Leoyklang; Carla Ciccone; Adrian Astiz-Martinez; Katherine Jacobs; Heidi M Dorward; Patricia M Zerfas; William A Gahl; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2012-10-18       Impact factor: 4.797

Review 10.  The hereditary inclusion body myopathy enigma and its future therapy.

Authors:  Zohar Argov; Stella Mitrani-Rosenbaum
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.